Table 8. Initial Biomarker Levels and Changes in Swallowing Solids From Baseline at 6 and 12 Months.
6-month change | 12-month change | |||
---|---|---|---|---|
Biomarker | Β | p value | Β | p value |
IL-β1 | 0.26 | 0.057 | 0.25 | 0.060 |
IL-6 | 0.34 | 0.009 | 0.36 | 0.006a |
IL-8 | 0.22 | 0.107 | 0.21 | 0.116 |
IL-10 | 0.31 | 0.023 | 0.39 | 0.003a |
IL-12p70 | –0.04 | 0.770 | –0.11 | 0.394 |
MMP2A | 0.03 | 0.828 | 0.16 | 0.233 |
MMP9A | 0.16 | 0.262 | 0.11 | 0.416 |
TGF-β1 | –0.17 | 0.223 | –0.11 | 0.445 |
TGF-β2 | –0.12 | 0.399 | –0.14 | 0.303 |
TGF-β3b | –0.17 | 0.448 | –0.10 | 0.628 |
TNFα | 0.31 | 0.019a | 0.23 | 0.091 |
IFNγ | –0.07 | 0.625 | –0.05 | 0.711 |
CRP | –0.09 | 0.509 | –0.15 | 0.253 |
RBC | 0.18 | 0.198 | 0.24 | 0.085 |
Albumin | –0.15 | 0.292 | –0.27 | 0.048a |
Note. IL = interleukin; MMP = matrix metalloproteinase; TGF = transforming growth factor; TNF = tumor necrosis factor; IFN = interferon; CRP = C-reactive protein; RBC = red blood cell.
Statistically significant.
N = ∼25 with data for TGF-β3 pretreatment, 6 and 12 months posttreatment.